- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT05743153
Fattibilità di un programma di intervento multimodale per ottimizzare i risultati del trattamento nella colite ulcerosa (OPTIMIZE-UC)
OPTIMIZE-UC: fattibilità di un programma di intervento multimodale per ottimizzare i risultati del trattamento nella colite ulcerosa: uno studio pilota prospettico
This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in Ulcerative Colitis (UC) patients with active disease as well as in patients in remission. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Rationale: Despite considerable advances in the knowledge of UC, and a variation of treatment options, UC still impacts patients' ability to lead a normal life. Clearly, there is an unmet need to improve treatment outcomes. Prehabilitation programs in surgery have shown that the amount of complications is closely related to preoperative physical fitness, nutritional status and psychological well-being. IBD patients often search for self-management strategies to manage their symptoms, however, research focussing on a multimodal intervention approach in parallel to starting new IBD treatment is lacking. Given the potential benefits of intervention programs, limitations of current treatments in terms of improving quality of life and patients' desire for self-management options, we believe that exploring the results of a multimodal intervention program in patients with UC is of high relevance.
Objective/study design: This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in UC patients. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes.
Study population: Patients ≥ 18 years old, with UC. Intervention: Multimodal intervention program including an exercise program, nutritional intervention and psychological evaluation.
Main study parameters/endpoints: This study assesses the feasibility of a multimodal intervention program. Secondary, assesses the effect on:
- Individual patients' level, i.e. physical fitness, nutritional status, mental health, quality of life and work productivity and activity impairment.
- Therapy outcomes, e.g. adherence, number and severity of (S)AEs, corticosteroid use, biochemical and clinical response/remission rates and patient reported outcomes.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Nijmegen, Olanda, 6525GA
- Dorien Oomkens
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Age ≥ 18 years old;
- Diagnosis of UC confirmed by clinical, endoscopic, and/or histological evidence prior to screening as per standard criteria;
- Ability of subject to participate fully in all aspects of this project;
- Written informed consent must be obtained and documented.
Exclusion Criteria:
- Suspicion of differential diagnosis of CD, indeterminate colitis, ischemic colitis, radiation colitis, diverticular disease associated with colitis, or microscopic colitis;
- Serious underlying disease other than UC that in the opinion of the investigator may interfere with the subject's ability to participate fully in the study or would compromise subject safety (such as history of malignancies, major neurological disorders, certain orthopedic impairments or any unstable, uncontrolled or severe systemic medical disorder);
- History of alcohol or drug abuse that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures;
- History of psychiatric disorders that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures;
- If female, the subject is pregnant or lactating (< 1 year) or intending to become pregnant;
- Immobilized patients who are not able to complete exercise intervention;
- Illiteracy (disability to read and understand Dutch).
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Patients with ulcerative colitis
Patients participate in multimodal intervention |
Exercise intervention: combined endurance and resistance training three times a week using workout video's which patients can do at home. Advice to exercise at low-intensity for at least 30 minutes per day. Nutritional intervention: Patients are advised to aim for optimal energy and protein intake (by registered dietician) and to avoid red meat, processed foods and sweetened drinks. Aiming for a mainly plant based diet. Psychological intervention: screening for psychological risk factors and if present, patients are referred to a psychologist for psychological support. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Accrural
Lasso di tempo: 24 weeks
|
The percentage of approached, eligible participants that are included in the study. |
24 weeks
|
|
Attrition
Lasso di tempo: 24 weeks
|
The percentage of participants who stopped the program prematurely. |
24 weeks
|
|
Adherence to exercise program
Lasso di tempo: 24 weeks
|
Frequency of followed trainings |
24 weeks
|
|
Adherence to daily exercise goals
Lasso di tempo: 24 weeks
|
SQUASH questionnaire |
24 weeks
|
|
Patient satisfaction
Lasso di tempo: 24 weeks
|
Measured using a patient satisfaction questionnaire |
24 weeks
|
|
Safety and adverse events
Lasso di tempo: 24 weeks
|
Measured by the number of adverse events occurring during the program |
24 weeks
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Oxygen Consumption (VO2 max)
Lasso di tempo: 1 year
|
Indication of physical fitness |
1 year
|
|
Change in 1 repitition measures
Lasso di tempo: 1 year
|
Indication of muscle strength |
1 year
|
|
Change in body weight
Lasso di tempo: 1 year
|
Measured in kilograms |
1 year
|
|
Change in fat-free mass
Lasso di tempo: 1 year
|
Measured with bioelectrical impedance analysis (BIA) |
1 year
|
|
Change in nutritional status
Lasso di tempo: 1 year
|
Measured with Patient Generated Subjective Global Assessment (PG-SGA) |
1 year
|
|
Change in mental health
Lasso di tempo: 1 year
|
Hospital Anxiety and Depression scale (HADS questionnaire) |
1 year
|
|
Change in Work Productivity and Activity Impairment
Lasso di tempo: 1 year
|
Work Productivity and Activity Impairment Questionnaire (including WPAI-GH) |
1 year
|
|
Change in 36-Item Short Form Health Survey (SF-36) score
Lasso di tempo: 1 year
|
Quality of life |
1 year
|
|
Change in EuroQoL (EQ-5D-5L) score
Lasso di tempo: 1 year
|
Quality of life |
1 year
|
|
Change in Inflammatory Bowel Disease Questionnaire score
Lasso di tempo: 1 year
|
Disease-related quality of life |
1 year
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 114110
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .